MERCK Kommanditgesellschaft auf Aktien (MKGAF PINK) stock market data APIs
$130.5126
0(0%)
as of July 18, 2025
Try our APIs with
free plan!
MERCK Kommanditgesellschaft auf Aktien Financial Data Overview
Price chart is built with
Anychart
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Prev. Close
130.5126
Open
130.5126
High
130.5126
Low
130.5126
52 wk Range
116.0964-197.241
Market Cap
56 429 M
P/E Ratio
17.524
Shares Outstanding
129 M
Revenue
21 316 M
EPS
1.7792
Dividends (Yield)
0.0191
Beta
0.641
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MERCK Kommanditgesellschaft auf Aktien data using free add-ons & libraries
Get MERCK Kommanditgesellschaft auf Aktien Fundamental Data
MERCK Kommanditgesellschaft auf Aktien Fundamental data includes:
- Net Revenue: 21 316 M
- EBITDA: 5 877 M
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-15
- EPS/Forecast: NaN
Get MERCK Kommanditgesellschaft auf Aktien End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MERCK Kommanditgesellschaft auf Aktien News
New
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
SpringWorks Therapeutics, Inc. – EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder wi...
Medical Filtration Company Benchmark Report 2025 | Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers
Company Logo The Medical Filtration Companies Quadrant offers a detailed analysis of the global medical filtration market, spotlighting key players, technological advancements, and market trends. Thi...
Microfiltration Membranes Company Evaluation Report 2024-2025 | Merck and Veolia Lead in Microfiltration Market with Strategic Moves
Company Logo The Microfiltration Membrane Market Companies Quadrant offers an in-depth analysis of the global microfiltration segment, spotlighting technological advancements and key market trends. I...
Sustainability Driving Global Innovation: Highlights From MilliporeSigma at Sustainability LIVE Chicago 2025
NORTHAMPTON, MA / ACCESS Newswire / July 17, 2025 / "Sustainability for sustainability's sake doesn't often work. We have found a lot of ways to connect it to the business and business value." This i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
